Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_assertion type Assertion NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_head.
- NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_assertion description "[The aim of our study is to evaluate the interest of HLA class II and TAP genetic markers to identify different clinical forms of UC, according to p-ANCA status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_provenance.
- NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_assertion evidence source_evidence_literature NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_provenance.
- NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_assertion SIO_000772 9115580 NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_provenance.
- NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_assertion wasDerivedFrom befree-20140225 NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_provenance.
- NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_assertion wasGeneratedBy ECO_0000203 NP247362.RAkqHPCezQ7YoEaRMm8HBdYKhg5JmbXm-ZPD5jNYGVDVs130_provenance.